Biotech 2012 - Pre-Formulation and Formulation Development of a Sound Bio Pharmaceutical Formulation that is cGMP Compliant
Date2012-05-10
Deadline2012-05-10
VenuePalo Alto, USA - United States
KeywordsLyophilization Technology; Bio Pharmaceutical Formulation; cGMP Compliance; cycle design; lyophilized products; thermal analysis; Pre-Formulation Development; Formulation Development
Topics/Call fo Papers
This webinar on lyophilization technology will provide you the understanding required to develop an optimized, cGMP compliant formulation that is specifically designed for lyophilization.
Why Should You Attend:
The Food and Drug Administration (FDA) is becoming more and more educated in the practice and science of lyophilization. As such, they are asking more questions about lyophilization during NDA or ANDA document reviews, site visits to companies producing lyophilized products, etc.
Areas Covered in the Seminar:
- Pre-formulation assessment.
- Selecting acceptable formulation components.
- Buffers and buffer capacity.
- Antioxidants, stabilizers, surfactants, bulking agents, complexing agents, cosolvents.
- Crystalline vs. amorphous vs. mixed systems.
- Eutectic melting, glass transition, and collapse temperatures.
- Thermal characterization techniques.
- Filling and fill volume.
- Biomolecule stabilization theory.
- Excipient considerations.
- Infrared analysis of proteins.
Other CFPs
- Designing Effective and Efficient Extractables/Leachables Studies for Biologics
- Conducting EU Studies from a US Virtual Biotech Company
- Container Closure Systems for Liquid and Lyophilized Products
- Auditing Systems for 21 CFR Part 11 Compliance: Preparing Yourself for Inspection
- 21 CFR Part 11 compliance for Electronic Medical Records
Last modified: 2012-04-05 20:33:08